Lomitapide distribution agreements signed in the UAE and Bahrain between Amryt Pharma PLC and Goro Healthcare:
Lomitapide distribution agreements signed in the UAE and Bahrain between Amryt Pharma PLC and Goro Healthcare:
Amryt, a biopharmaceutical company focused on rare and orphan diseases, is pleased to announce the signing of four further distribution agreements for Lomitapide® (lomitapide) across the Middle East, where the incidence of Homozygous Familial Hypercholesterolaemia ("HoFH"), the rare cholesterol disorder treated by Lomitapide, is relatively high. The distribution agreements have been signed with